NMDA antagonists under investigation for the treatment of major depressive disorder
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NMDA antagonists under investigation for the treatment of major depressive disorder
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 9, Pages 1181-1192
Publisher
Informa Healthcare
Online
2014-05-12
DOI
10.1517/13543784.2014.918951
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glutamate Receptor Antagonists as Fast-Acting Therapeutic Alternatives for the Treatment of Depression: Ketamine and Other Compounds
- (2014) Mark J. Niciu et al. Annual Review of Pharmacology and Toxicology
- Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test
- (2014) Małgorzata Wolak et al. Pharmacological Reports
- Glutamate-Based Antidepressants: Preclinical Psychopharmacology
- (2013) Andrzej Pilc et al. BIOLOGICAL PSYCHIATRY
- Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
- (2013) John H. Krystal et al. BIOLOGICAL PSYCHIATRY
- Pharmacological Properties of Glutamatergic Drugs Targeting NMDA Receptors and their Application in Major Depression
- (2013) Gianluca Serafini et al. CURRENT PHARMACEUTICAL DESIGN
- GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists
- (2013) Joseph R Moskal et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Riluzole increases glutamate uptake by cultured C6 astroglial cells
- (2013) Oscar P. Dall’Igna et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression
- (2013) Paulo R. Shiroma et al. JOURNAL OF AFFECTIVE DISORDERS
- Ketamine regulates the presynaptic release machinery in the hippocampus
- (2013) Heidi Kaastrup Müller et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Ketamine, magnesium and major depression – From pharmacology to pathophysiology and back
- (2013) Harald Murck JOURNAL OF PSYCHIATRIC RESEARCH
- Glycine site N-methyl-D-aspartate receptor antagonist 7-CTKA produces rapid antidepressant-like effects in male rats
- (2013) Wei-Li Zhu et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- mTORC1-dependent protein synthesis underlying rapid antidepressant effect requires GABABR signaling
- (2013) E.R. Workman et al. NEUROPHARMACOLOGY
- GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects
- (2013) Jeffrey Burgdorf et al. NEUROPSYCHOPHARMACOLOGY
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain
- (2013) Juan M. Lima-Ojeda et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR
- (2013) Luli Akinfiresoye et al. PSYCHOPHARMACOLOGY
- Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers and Depressed Patients
- (2013) Kari R. Nations et al. Drugs in research & development
- Ketamine for Depression: Where Do We Go from Here?
- (2012) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- On the Safety and Benefits of Repeated Intravenous Injections of Ketamine For Depression
- (2012) Pierre Blier et al. BIOLOGICAL PSYCHIATRY
- A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- Targeting the Glutamatergic System to Treat Major Depressive Disorder
- (2012) Daniel C. Mathews et al. DRUGS
- A randomized add-on trial of high-dose d-cycloserine for treatment-resistant depression
- (2012) Uriel Heresco-Levy et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial
- (2012) Kari R Nations et al. JOURNAL OF PSYCHOPHARMACOLOGY
- NMDA Receptor-Mediated PIP5K Activation to Produce PI(4,5)P2 Is Essential for AMPA Receptor Endocytosis during LTD
- (2012) Takamitsu Unoki et al. NEURON
- Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study
- (2012) Lobna Ibrahim et al. NEUROPSYCHOPHARMACOLOGY
- Lamotrigine treatment reverses depressive-like behavior and alters BDNF levels in the brains of maternally deprived adult rats
- (2012) Helena M. Abelaira et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress
- (2012) Agata Chandran et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
- (2012) Kenji Hashimoto PROGRESS IN NEUROBIOLOGY
- A pivotal role of GSK-3 in synaptic plasticity
- (2012) Clarrisa A. Bradley et al. Frontiers in Molecular Neuroscience
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- The size and burden of mental disorders and other disorders of the brain in Europe 2010
- (2011) H.U. Wittchen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Investigational NMDA receptor modulators for depression
- (2011) Bernadeta Szewczyk et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression
- (2011) James G. Barbee et al. JOURNAL OF CLINICAL PSYCHIATRY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Signaling pathways underlying the rapid antidepressant actions of ketamine
- (2011) Ronald S. Duman et al. NEUROPHARMACOLOGY
- Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression
- (2011) Lobna Ibrahim et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
- (2011) Courtney S. Jernigan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Differential trafficking of AMPA receptors following activation of NMDA receptors and mGluRs
- (2011) Thomas M Sanderson et al. Molecular Brain
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Riluzole rapidly attenuates hyperemotional responses in olfactory bulbectomized rats, an animal model of depression
- (2010) Kou Takahashi et al. BEHAVIOURAL BRAIN RESEARCH
- Brain-derived neurotrophic factor signalling mediates antidepressant effects of lamotrigine
- (2010) Nanxin Li et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm
- (2010) Severine Farley et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
- (2010) Nancy DiazGranados et al. JOURNAL OF CLINICAL PSYCHIATRY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Regulation of NMDA receptor Ca2+signalling and synaptic plasticity
- (2009) C. Geoffrey Lau et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
- (2009) Rebecca B. Price et al. BIOLOGICAL PSYCHIATRY
- Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
- (2009) S. E. Kotermanski et al. JOURNAL OF NEUROSCIENCE
- The N-methyl-d-aspartate receptor modulator GLYX-13 enhances learning and memory, in young adult and learning impaired aging rats
- (2009) Jeffrey Burgdorf et al. NEUROBIOLOGY OF AGING
- Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole
- (2009) Brian P Brennan et al. NEUROPSYCHOPHARMACOLOGY
- Oral Administration of the NMDA Receptor Antagonist S-Ketamine as Add-On Therapy of Depression: A Case Series
- (2009) G. Paslakis et al. PHARMACOPSYCHIATRY
- Glutamate-based antidepressants: 20 years on
- (2009) Phil Skolnick et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Family History of Alcohol Dependence and Initial Antidepressant Response to an N -methyl-D-aspartate Antagonist
- (2008) Laura E. Phelps et al. BIOLOGICAL PSYCHIATRY
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Lack of NMDA–AMPA interaction in antidepressant-like effect of CGP 37849, an antagonist of NMDA receptor, in the forced swim test
- (2008) Małgorzata Dybała et al. JOURNAL OF NEURAL TRANSMISSION
- The Role of Hippocampal GluR1 and GluR2 Receptors in Manic-Like Behavior
- (2008) J. Du et al. JOURNAL OF NEUROSCIENCE
- Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole
- (2008) M Banasr et al. MOLECULAR PSYCHIATRY
- A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral–CA1 synapses in hippocampus
- (2008) Xiao-lei Zhang et al. NEUROPHARMACOLOGY
- Comparison of racemic ketamine andS-ketamine in treatment-resistant major depression: Report of two cases
- (2008) Robert Paul et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search